Article info

Download PDFPDF

Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic
Free

Authors

  1. Correspondence to Dr Safak Yilmaz Baran, Baskent Universitesi Adana Uygulama ve Arastirma Merkezi, Adana 01120, Turkey; safakyilmazbaran{at}gmail.com
View Full Text

Citation

Ayhan A, Yilmaz Baran S, Vatansever D, et al
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic

Publication history

  • Received February 8, 2021
  • Revision received April 5, 2021
  • Accepted April 8, 2021
  • First published April 15, 2021.
Online issue publication 
June 07, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.